Pfizer EBITDA 2010-2024 | PFE

Pfizer EBITDA for the quarter ending December 31, 2024 was $4.138B, a 258.06% decline year-over-year.

  • Pfizer 2024 EBITDA was 19.424B, a 156.63% increase from 2023.
  • Pfizer 2023 EBITDA was 7.569B, a 81.47% decline from 2022.
  • Pfizer 2022 EBITDA was 40.853B, a 65.91% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Pfizer EBITDA 2010-2024 | PFE

  • Pfizer 2024 EBITDA was 19.424B, a 156.63% increase from 2023.
  • Pfizer 2023 EBITDA was 7.569B, a 81.47% decline from 2022.
  • Pfizer 2022 EBITDA was 40.853B, a 65.91% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B